Skip to main content

MOB · Moberg Pharma AB (publ)

11.1400 SEK +0.1400 (+1.27%) At close · Oct 2
Market Cap
532.20M SEK
Shares
47.18M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Investor day
Close11.1400 SEK Open10.9800 SEK Day10.8200–11.1400 SEK 52W close7.7900–12.4000 SEK Avg vol 30d50K Last earningsNov 12, 2026 DataMay 2023–Oct 2026

Raw chart and full-history price indicators begin at the captured split on May 24, 2023; bars on opposite sides are not compared.

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 7.7900 SEK Now 11.1400 SEK · 73% Range high 12.4000 SEK
vs 200-day avg +9% vs 50-day avg +4%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

Raw-price comparisons begin at the captured split on May 24, 2023; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
XSTO:MOB -1.1% -1.9% +7.3% -1.4% +8.5%

Exchange listing

Market
XSTO
Ticker
MOB
ISIN
SE0020353928
Security
—
Trading currency
SEK

Other listings of this company

No other verified listings are available.

Recent dividends

No verified dividend payments are available for this listing yet.

Upcoming investor events

DateEventType
2026-11-09 00:00 UTC BIO-Europe 2026 Event
2026-11-12 00:00 UTC Interim report for January - September 2026 Results publication
2026-11-18 00:00 UTC Redeye Licensing and Deals in Life Science Event
2026-12-02 00:00 UTC Redeye Life Science Day Event
2027-01-11 00:00 UTC JPM Annual Healthcare Conference 2027 Conference
2027-03-19 00:00 UTC AAD Annual Meeting 2027, San Fransisco Shareholder meeting
2027-04-24 00:00 UTC BIO-Europe spring 2027 Event
2027-06-07 00:00 UTC BIO International Convention 2027 Event

Earnings calls

  • Annual General Meeting · March 2027 2027-03-19 Scheduled
    AAD Annual Meeting 2027, San Fransisco
  • Conference · January 2027 2027-01-11 Scheduled
    JPM Annual Healthcare Conference 2027
  • Earnings call · Q3 2026 2026-11-12 Scheduled
    Interim report for January - September 2026
  • Earnings call · Q2 2026 2026-08-13
    Interim report for January - June 2026
  • Earnings call · Q1 2026 2026-05-12
    Interim report for January - March 2026